GB0808832D0 - Biomarkers for depression - Google Patents

Biomarkers for depression

Info

Publication number
GB0808832D0
GB0808832D0 GBGB0808832.0A GB0808832A GB0808832D0 GB 0808832 D0 GB0808832 D0 GB 0808832D0 GB 0808832 A GB0808832 A GB 0808832A GB 0808832 D0 GB0808832 D0 GB 0808832D0
Authority
GB
United Kingdom
Prior art keywords
late
depression
onset depression
biomarkers
onset
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0808832.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to GBGB0808832.0A priority Critical patent/GB0808832D0/en
Publication of GB0808832D0 publication Critical patent/GB0808832D0/en
Priority to JP2011508938A priority patent/JP2011523637A/ja
Priority to CN200980128132XA priority patent/CN102099489A/zh
Priority to EP09745832A priority patent/EP2281067A1/en
Priority to PCT/EP2009/055944 priority patent/WO2009138500A1/en
Priority to US12/991,925 priority patent/US8562950B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB0808832.0A 2008-05-15 2008-05-15 Biomarkers for depression Ceased GB0808832D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0808832.0A GB0808832D0 (en) 2008-05-15 2008-05-15 Biomarkers for depression
JP2011508938A JP2011523637A (ja) 2008-05-15 2009-05-15 うつ病に関するｇａｂａバイオマーカー
CN200980128132XA CN102099489A (zh) 2008-05-15 2009-05-15 抑郁症的gaba生物标记
EP09745832A EP2281067A1 (en) 2008-05-15 2009-05-15 Gaba biomarkers for depression
PCT/EP2009/055944 WO2009138500A1 (en) 2008-05-15 2009-05-15 Gaba biomarkers for depression
US12/991,925 US8562950B2 (en) 2008-05-15 2009-05-15 GABA biomarkers for depression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0808832.0A GB0808832D0 (en) 2008-05-15 2008-05-15 Biomarkers for depression

Publications (1)

Publication Number Publication Date
GB0808832D0 true GB0808832D0 (en) 2008-06-18

Family

ID=39571406

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0808832.0A Ceased GB0808832D0 (en) 2008-05-15 2008-05-15 Biomarkers for depression

Country Status (6)

Country Link
US (1) US8562950B2 (https=)
EP (1) EP2281067A1 (https=)
JP (1) JP2011523637A (https=)
CN (1) CN102099489A (https=)
GB (1) GB0808832D0 (https=)
WO (1) WO2009138500A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808834D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
GB0808833D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
US20130046093A1 (en) * 2011-08-18 2013-02-21 Korea Institute Of Science And Technology Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same
AU2013329000A1 (en) * 2012-10-12 2015-04-30 Northwestern University Methods of identifying compounds for treating depression and other related diseases
US20180348195A1 (en) * 2015-11-12 2018-12-06 Kyushu University, National University Corporation Biomarker for diagnosing depression and use of said biomarker
JP7264384B2 (ja) 2019-03-29 2023-04-25 日本たばこ産業株式会社 うつ病の評価を補助するための方法及びうつ病の治療法の効果の評価を補助するための方法、並びにうつ病若しくはうつ病の治療法の効果を評価するためのデータを取得する方法
CN111944835B (zh) * 2019-05-14 2022-03-29 南通大学 一种突变型gabrg2转基因斑马鱼癫痫模型的构建方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040114A1 (en) 1998-02-05 1999-08-12 Merck & Co., Inc. Novel gabab receptor dna sequences
US7247442B1 (en) * 1998-05-12 2007-07-24 Human Genome Sciences, Inc. Antibodies to HHPEN62 polypeptide
JP2004508359A (ja) 2000-09-06 2004-03-18 ニューロゲン　コーポレイション アリール置換テトラヒドロインダゾール、及び、ｇａｂａ−ａ受容体に対するリガンドとしてのそれらの使用
WO2004047727A2 (en) * 2002-11-01 2004-06-10 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for diagnosing and treating mood disorders
US20050209181A1 (en) * 2003-11-05 2005-09-22 Huda Akil Compositions and methods for diagnosing and treating mental disorders
DK1766077T3 (da) 2004-06-21 2012-07-16 Univ Leland Stanford Junior Differentielt udtrykte gener og veje i bipolar forstyrrelse og/eller alvorlig depressiv forstyrrelse
WO2008020435A2 (en) 2006-08-15 2008-02-21 Quark Pharmaceuticals, Inc Compositions and methods for treatment of mood disorders
GB0808834D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
GB0808833D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression

Also Published As

Publication number Publication date
CN102099489A (zh) 2011-06-15
JP2011523637A (ja) 2011-08-18
EP2281067A1 (en) 2011-02-09
WO2009138500A1 (en) 2009-11-19
US8562950B2 (en) 2013-10-22
US20110091381A1 (en) 2011-04-21

Similar Documents

Publication Publication Date Title
GB0808834D0 (en) Biomarkers for depression
GB0808832D0 (en) Biomarkers for depression
WO2008125651A3 (en) Biomarkers for multiple sclerosis
WO2009153775A3 (en) Methods for distinguishing between specific types of lung cancers
EP3296406A3 (en) Mirna fingerprint in the diagnosis of lung cancer
WO2010062377A3 (en) Methods and compositions for the detection and treatment of preeclampsia
WO2011031786A3 (en) Compositions and methods for diagnosing autism spectrum disorders
WO2010099161A8 (en) Micrornas in never-smokers and related materials and methods
WO2011087760A3 (en) Processes and kits for identifying aneuploidy
WO2013003350A3 (en) Microrna biomarkers indicative of alzheimer's disease
WO2008097277A3 (en) Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
WO2009117421A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
WO2007146057A3 (en) Screening method for modulators of viral transcription or replication
WO2006110783A3 (en) Process for making (s)-pregabalin
WO2009120712A3 (en) Compositions and methods for diagnosing and treating melanoma
WO2009156179A8 (en) Her3 as a determinant for the prognosis of melanoma
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
WO2007047408A3 (en) Promac signature application
SA112330754B1 (ar) طريقة تشخيصية للكشف عن مرض قلبي وعائي
WO2012167086A3 (en) Methods of diagnosing and treating amyotrophic lateral sclerosis
GB0808833D0 (en) Biomarkers for depression
WO2007100777A3 (en) Methods for the treatment of adhd and related disorders
WO2011143575A3 (en) smFRET WITH MEMBRANE PROTEINS
WO2010046648A3 (en) Diagnostic test for streptococcus equi
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)